ATP: Velocity and capital for highly differentiated early-stage companies with clear competitive advantages, diverse teams and deep technology.

 

We are an early stage firm generating market-leading returns from the complexities of innovation — We see INNOVATION as an emerging ASSET CLASS
 
Our mission – The advancement of science and engineering from the brightest research minds and entrepreneurs into the market by reverse engineering the traditional VC model, with the goals of both benefitting society and generating sustainable economics for all of our stakeholders.

Our Team’s Proven Results

0
Years of Venture Experience
0
$Million of Cumulative Funding
0
$Billion in Exits
0
Companies
0
IPO’s
0
M&A’s
early stage Venture

About Us

ATP is an early stage venture capital organization changing the way research-borne innovations impact the world. We are not a traditional VC, we are a platform. A platform of interconnected resources with the mission of creating tangible value from the brightest, yet most underserved minds in society.

Example area of focus: US Heartland & Canadian universities receive over $58B of research funding annually yet are severely under utilized by the traditional venture capital industry. ATP works directly with innovators from the early research-translation to later phases, with particular emphasis on Pre-seed (Launch), Seed (Nurture) and Series A (Scale) funding stages. ATP powers the earliest stages of firm development, creating returns for our investors and sustainable impact in such focus areas as: gender-disparity access and economic development in underserved regions.

The ATP team brings together the critical components of the Research-to-Development (R-to-D) ecosystem, specifically: INNOVATORS with national lab, university, and corporate R&D groups; ENTREPRENEURS: both first-time and seasoned executives, INVESTMENT PARTNERS: top-tier VC firms and our own syndication networks; and CORPORATIONS: the key stakeholder to ensure Demand meets Supply. This diversity brings value-add from zero to one and beyond.

Where We Look

Emerging Research Technologies

Currently over 140 proto-startups at universities across the US heartland

Health

Behavioral research, Biomedical Technologies, Bioinformatics / Computational biology, Nanotechnologies, Devices (Dx and Tx), Proteomics / Genomics, and Women’s health

Infrastructure

Materials science, Energy – Alternative & Traditional, Infrastructure, Transportation

Enterprise Innovation

AI & cognitive computing, blockchain, 3D printing & imaging, online commerce, supply chain/logistics

Why Now?

Early-stage VC continues to outperform, Global cash is still seeking yields, Formation & early-stage is where wealth is created
Overlooked, underserved, and complex markets are ripe for more early-stage venture funding
Result of team’s long-standing corporate & university & national research lab relationships
Following existing “best-in-class” incubation organizations with our own proven “ATP-Activation” acceleration process enhances the resources available to portfolio investments